Department of Dermatology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Clinic 5C, Spokane, WA.
J Am Acad Dermatol. 2023 Sep;89(3):560-568. doi: 10.1016/j.jaad.2020.03.115. Epub 2020 Apr 11.
Visible light has been used therapeutically in dermatology for years for a variety of cosmetic and medical indications, including skin rejuvenation and the treatment of inflammatory and neoplastic conditions, among others. Until recently, visible light was thought to be relatively inert compared to its spectral neighbors, ultraviolet and infrared radiation. However, recent literature has described the ability of visible light to cause erythema in light skin and pigmentary changes in individuals with darker skin types. Concern surrounding its potentially damaging cutaneous effects has been raised in both the medical community and social media outlets. In this article, we provide an evidenced-based review describing what is currently known about visible light, focusing on its role in dermatologic diseases including disorders of hyperpigmentation such as melasma and postinflammatory hyperpigmentation.
可见光在皮肤科领域已被用于治疗多种美容和医学病症多年,包括皮肤年轻化和治疗炎症及肿瘤等病症。直到最近,可见光才被认为与紫外线和红外线辐射相比相对惰性。然而,最近的文献描述了可见光在浅色皮肤中引起红斑和在深色皮肤类型个体中引起色素变化的能力。在医学社区和社交媒体渠道中,都对其潜在的皮肤损伤作用表示担忧。在本文中,我们提供了一个基于证据的综述,描述了目前已知的关于可见光的知识,重点介绍了它在皮肤科疾病中的作用,包括色素沉着紊乱,如黄褐斑和炎症后色素沉着过度。